If, like me, you’ve been wondering what the pharmaceutical companies have been doing in response to the terrible events surrounding Ebola, here’s a two minute video from Reuters that offers some useful insight. The video discusses Johnson and Johnson, GSK and some investor perspectives. Apparently JnJ and GSK may collaborate on vaccines, according to the video.
This risk briefing that just came out today on Ebola and the reporting of it is also useful.